Phase 1 clinical trial
Also known as: Phase 1 trial, Phase I trial, first-in-human trial, Phase 1 study
A Phase 1 clinical trial is the first stage of testing an investigational drug in humans. Its main goals are to assess safety and tolerability, find a safe dose range, and measure pharmacokinetics (how the body absorbs, distributes, metabolizes and clears the drug).
How it works
Phase 1 begins once an IND is in effect. Studies typically enroll about 20 to 100 participants. For most drugs these are healthy volunteers, but in oncology and some severe diseases the trials enroll patients, since the drugs may be too toxic for healthy people.
Common designs include:
- Single ascending dose (SAD): small groups receive one dose, with each group getting a higher dose than the last if safety allows.
- Multiple ascending dose (MAD): the same approach with repeated dosing.
- Dose escalation in patients to find the maximum tolerated dose or recommended Phase 2 dose.
Some programs run combined Phase 1/2 trials that add expansion cohorts to look for early efficacy.
Why it matters for traders
Phase 1 data are mostly about safety, so the bar for a positive readout is "no unexpected problems". Exceptions draw big moves: patient-enrolling oncology and rare-disease trials can show early efficacy signals such as tumor responses or biomarker changes, and those can rerate a small-cap biotech. Serious adverse events or a clinical hold can do the opposite. Small sample sizes mean early efficacy numbers can shift substantially as more patients are dosed.
Example
Northwind Therapeutics (NWTX) runs a dose-escalation Phase 1 in 24 patients with an advanced solid tumor, enrolled in cohorts of three to six. At the two highest doses, 4 of 12 patients show tumor shrinkage, a 33% response rate. The company selects a recommended Phase 2 dose and the stock rallies on the early signal.
FAQ
What is the main purpose of a Phase 1 trial?
To establish safety and dosing. Efficacy is usually not the primary goal.
Are Phase 1 trial participants healthy?
Often, but not always. Cancer and some rare disease trials enroll patients from the start.
Track it on Quantisnow
Related terms
Part of the Quantisnow financial glossary. For longer explainers, see the investing guides. Educational content, not investment advice.